There were no significant associations observed in the placebo arm, however, in the finasteride arm, several SNPs in APEX1, OGG1, NOS3, LIG3 and XRCC1 were associated with risk of total, low- or high-grade prostate cancer. Here, OGG1 is linked to prostate cancer.